RAP 0.00% 20.5¢ resapp health limited

rap chart, page-1254

  1. 188 Posts.
    lightbulb Created with Sketch. 109
    HeyMr.Red,wereallydontneedalengthypostaboutyour"badfeelings"andselfcongratulating.Ifyou'vegotsomesubstantiatedinformationasto'why'peoplearesellingatthesepricesthatwouldbeuseful.Yougettingscaredbecausepeoplearesellingisnotahelpfulpost.

    Iappreciateeveryoneisentitledtotheiropinionandallbutsometimesitreallydoesn'twarrantapost.Maybegetoutsideandtalktosomeone.RAPistravellingalongfine.CEwasamajorhurdlewhichtheyhaveovercome.Itsnowtimetostartseekingcommercialdealsandimplementtherollingscheduleofadditionalapprovalsthecompanyhasstated.IfullyexpecttheSPtocontinuetorisewitheachnewannouncement(nothwistandinganymajorsetbackslikenotreceivingFDA).
    Well put Sonny. It's similar to his fear mongering post on 28/08/19 13:21 Post #: 40195696 when he suggested that it was looking as though the SP would retrace until @djwally schooled him. His follow up post to cover his ass was something like: I meant consolidate not retrace - stop being so nasty!

    There have been plenty of buys over $10k. I know. One of them was mine. The SP is still well below previous highs and now we have an approval locked away. Even a minor announcement stating we're on track with with negotiations or an MOU for example will bump us up a little until the big ones, like FDA approval come through.

    On another note, plenty of talk about a take over. In reality, take overs are pretty rare compared to how many times they are talked about on HC with spec stocks. Not gonna happen.

    Also, to sell the OSA tech as some have mentioned would be very short-sighted. That's a cash cow just waiting to be milked. Multiple, easily scalable streams of revenue will make RAP a mega success and a win for everyone involved.

    Good to see a few hawk eyes on the threads telling it how it is.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.